RespireRx Pharmaceuticals Inc (fka RSPI)

[Menace212]

That’s for the Australian exchange who knows how many shares are available on the market when they get listed. We are at 983m if they list at 100m there will be a price discrepancy which we will have to do the math to see where we land in comparison. However 25m osa valuation alone puts us right below 03c with their other compounds realistically gets us to a dime. 100m valuation in total. But of course BP or fda approval or success in human trials will all play a part and vary in our SP.